Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc Borsa (PTIX) Ultime notizie

Balance Sheet Breakdown: Protagenic Therapeutics Inc (PTIX)'s Debt-to-Equity and Long-Term Debt/Eq Ratios ... - The Dwinnex

The Dwinnex

Protagenic Therapeutics (NASDAQ:PTIX) Trading Down 6.6% - Defense World

Defense World

Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase ... - Yahoo Finance

Yahoo Finance

Paramount Global (NASDAQ:PARA) Lowered to “Neutral” at Seaport Res Ptn - Defense World

Defense World

Qurate Retail (QRTEB) to Release Earnings on Wednesday - Defense World

Defense World

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial - Yahoo Canada Finance

Yahoo Canada Finance

Likelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Substance (Drug) Abuse - GlobalData

GlobalData

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

“We owe it to our ancestors and future generations to regroup and rebuild”, Dr. Garo Armen - CIVILNET - CivilNet English

CivilNet English

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114 - Yahoo Finance

Yahoo Finance

The 5 Best Medical Stocks Under 5 Dollars - The Stock Dork

The Stock Dork

Meta-analysis Finds Antidepressants Ineffective for Children and Adolescents - Mad in America

Mad in America

Best Stocks Under $5 Right Now • Benzinga - Benzinga

Benzinga

Market Update: The 10 Most Volatile Stocks Today - InvestorPlace

InvestorPlace

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering - GlobeNewswire

GlobeNewswire

Protagenic Therapeutics Stock (NASDAQ:PTIX), Quotes and News Summary - Benzinga

Benzinga

Carlsmed Raises $2.5M to Accelerate Launch of Custom Spine Implant - https://ryortho.com/

https://ryortho.com/

Carlsmed Raises $2.5M to Improve Complex Spine Surgery - Business Wire

Business Wire

The next blockbuster? U of T startup Protagenic Therapeutics goes public on U.S. stock market - University of Toronto

University of Toronto

ADVFN - Free stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

ADVFN